Director/PDMR Shareholding

AI SummaryClose X

Idox plc announced that on April 22, 2026, four PDMRs exercised options and subsequently sold their ordinary shares at 71.5p per share as part of the unconditional cash offer by Frankel UK Bidco Limited. The CEO, David Meaden, exercised options for 1,837,455 shares and sold a total of 3,290,842 shares. The CFO, Anoop Kang, exercised options for 1,440,477 shares and sold 1,458,699 shares. The COO, Jonathan Legdon, exercised options for 1,317,258 shares and sold 2,174,969 shares. The Chair, Christopher Stone, exercised options for 585,500 shares and sold 1,521,877 shares, while NED Phil Kelly sold 105,263 shares. Following these transactions, the PDMRs no longer hold beneficial interests in the company. An application has been made for 13,160,839 new ordinary shares to be admitted to trading on AIM, expected on April 23, 2026, bringing the total number of ordinary shares with voting rights to 474,842,885.

Disclaimer*

Companies

IDOX (IDOX)
UK 100